Dynavax to Present at Newsmakers in the Biotech Industry Conference
(firmenpresse) - BERKELEY, CA -- (Marketwire) -- 10/14/11 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at the NewsMakers in the Biotech Industry Conference in New York on Friday, October 21, 2011 at 10:00 a.m. EDT (7:00 a.m. PDT).
Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a corporate overview presentation. To access the live webcast and the subsequent archived recording of the presentation, please log onto Dynavax's website at .
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and superior protection with fewer doses than current licensed vaccines. For more information visit .
Shari Annes
Investor Relations
510-665-7211
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.10.2011 - 10:27 Uhr
Sprache: Deutsch
News-ID 1046088
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
BERKELEY, CA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 95 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dynavax to Present at Newsmakers in the Biotech Industry Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Dynavax Technologies (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
